Abstract
Aims To determine immunohistochemical features and correlations between M1/M2 polarization status with disease severity of post-cesarean scar diverticulum (CSD).
Methods Histological and immunohistological staining were performed and inflammatory (CD16, CD163, and TNF-α), fibrosis (α-SMA), and angiogenic (CD31) markers were examined in uterine tissues collected from patients with uterine scar diverticula (CSD) (n=37) and cesarean section (CS) (n=3).
Results CSD tissues have higher expression of α-SMA, TNF-α, CD16, and CD31 and lower expression of CD163 than CS tissue (P <0.05). Compared with adjacent tissues, thick-walled blood vessels, glands, and fibrotic sites have higher expression of α-SMA, TNF-α, and CD16. Statistical correlation was observed between the expression of CD16 and TNF-α (R = 0.693, P <0.001), α-SMA (R = 0.404, P <0.05), and CD31 (R = 0.253, P <0.05) in CSD tissues, especially with the ratio of CD16/CD163 (R = 0.590, P <0.01). A more significant difference was observed between the expression of CD16/CD163 and α-SMA (R = 0.556, P <0.001), TNF-α (R = 0.633, P <0.0001) and CD31 (R = 0.336, P <0.05) Statistical correlation.
Conclusion In this study, TNF-α, α-SMA, CD16, and CD31 proteins were overexpressed in all CSD cases, and CD16/CD163 was positively correlated with tissue inflammation, fibrosis, and neovascularization. Abnormal mononuclear macrophage infiltration may be involved in the origin and progression of CSD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Foshan Science and Technology Bureau (2020001006077).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the ethics committee of Shunde Hospital of Southern Medical University.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The authors declare that the data and material of this study are available within the article.
